Transcriptional Up-Regulation of SOD1 by CEBPD: A Potential Target for Cisplatin Resistant Human Urothelial Carcinoma Cells

Biochemical Pharmacology - Netherlands
doi 10.1016/j.bcp.2010.04.007
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Tubeimoside I Sensitizes Cisplatin in Cisplatin-Resistant Human Ovarian Cancer Cells (A2780/Ddp) Through Down-Regulation of ERK and Up-Regulation of P38 Signaling Pathways

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2011English

Inhibition of the EGFR/STAT3/CEBPD Axis Reverses Cisplatin Cross-Resistance With Paclitaxel in the Urothelial Carcinoma of the Urinary Bladder

Clinical Cancer Research
Cancer ResearchOncology
2016English

mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary

Clinical Cancer Research
Cancer ResearchOncology
2009English

Cisplatin-Based First-Line Therapy for Advanced Urothelial Carcinoma After Previous Perioperative Cisplatin-Based Therapy

Clinical Genitourinary Cancer
OncologyUrology
2015English

Post-Transcriptional Up-Regulation of TSC-22 by Ybx1, a Target of miR-216a, Mediates TGF-β-induced Collagen Expression in Kidney Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2010English

Transcriptional Regulation of hTREX84 in Human Cancer Cells

PLoS ONE
Multidisciplinary
2012English

Transcriptional Regulation of Human NANOG by Alternate Promoters in Embryonic Stem Cells

Journal of Stem Cell Research & Therapy
2012English

Phosphatidylinositol 3'-Kinase, mTOR, and Glycogen Synthase Kinase-3β Mediated Regulation of P21 in Human Urothelial Carcinoma Cells

BMC Urology
MedicineReproductive MedicineUrology
2011English

Proteasome Inhibitor PS-341 Induces Apoptosis in Cisplatin-Resistant Squamous Cell Carcinoma Cells by Induction of Noxa

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy